# Medifast Inc: filings

MED · NYSE · CIK 910329 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/med.md) · [Financials](/companies/med/financials.md) · [Filings](/companies/med/filings.md) · [Insiders](/companies/med/insiders.md)

## Reports and events: 323 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 438, 8-K 208, SC 13G/A 57, 10-Q 54, 3 29, SC 13G 20, 10-K 18, DEF 14A 18, 5 16, DEFA14A 14, SC 13D/A 13, 4/A 11, SCHEDULE 13G/A 11, ARS 6, S-8 6, UPLOAD 6, 8-K/A 5, 144 4, CORRESP 4, SCHEDULE 13G 4, SC 13D 3, 10-K/A 2, 3/A 2, 5/A 2, 8-A12B 2, NT 10-K 2, 11-K 1, 8-A12B/A 1, CERT 1, CERTNYS 1, PRE 14A 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 08:50 ET | [10-Q](/filings/0001628280-26-067165.md) | Quarterly report, period 2026-09-30 | 0001628280-26-067165 |
| 2026-10-26 | 08:11 ET | [8-K](/filings/0001628280-26-067151.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-067151 |
| 2026-08-21 | 16:01 ET | [SCHEDULE 13D/A](/filings/0001213900-26-092590.md) | Ownership report, active investor, amended | 0001213900-26-092590 |
| 2026-08-03 | 16:50 ET | [10-Q](/filings/0001628280-26-051928.md) | Quarterly report, period 2026-06-30 | 0001628280-26-051928 |
| 2026-08-03 | 16:12 ET | [8-K](/filings/0001628280-26-051845.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-051845 |
| 2026-07-17 | 08:33 ET | [8-K](/filings/0001628280-26-048574.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-048574 |
| 2026-06-01 | 08:59 ET | [8-K](/filings/0001628280-26-039293.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-039293 |
| 2026-05-26 | 16:26 ET | [8-K](/filings/0001628280-26-038109.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-038109 |
| 2026-05-04 | 16:51 ET | [10-Q](/filings/0001628280-26-029898.md) | Quarterly report, period 2026-03-31 | 0001628280-26-029898 |
| 2026-05-04 | 16:12 ET | [8-K](/filings/0001628280-26-029812.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-029812 |
| 2026-04-06 | 16:06 ET | [DEF 14A](/filings/0001628280-26-023890.md) | Proxy statement, period 2026-05-19 | 0001628280-26-023890 |
| 2026-03-20 | 12:55 ET | [SCHEDULE 13D](/filings/0001213900-26-032212.md) | Ownership report, active investor | 0001213900-26-032212 |
| 2026-03-20 | 08:35 ET | [8-K](/filings/0001628280-26-019983.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-019983 |
| 2026-02-17 | 16:54 ET | [10-K](/filings/0001628280-26-008656.md) | Annual report, period 2025-12-31 | 0001628280-26-008656 |
| 2026-02-17 | 16:44 ET | [8-K](/filings/0001628280-26-008641.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-008641 |
| 2026-01-05 | 09:02 ET | [8-K](/filings/0001628280-26-000235.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-000235 |
| 2025-11-03 | 16:51 ET | [10-Q](/filings/0001628280-25-048332.md) | Quarterly report, period 2025-09-30 | 0001628280-25-048332 |
| 2025-11-03 | 16:15 ET | [8-K](/filings/0001628280-25-048251.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-048251 |
| 2025-08-04 | 16:51 ET | [10-Q](/filings/0000910329-25-000016.md) | Quarterly report, period 2025-06-30 | 0000910329-25-000016 |
| 2025-08-04 | 16:07 ET | [8-K](/filings/0000910329-25-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000910329-25-000015 |
| 2025-06-20 | 16:59 ET | [8-K](/filings/0001628280-25-032457.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-032457 |
| 2025-04-29 | 16:10 ET | [DEF 14A](/filings/0001628280-25-020673.md) | Proxy statement, period 2025-06-18 | 0001628280-25-020673 |
| 2025-04-28 | 16:50 ET | [10-Q](/filings/0001628280-25-020341.md) | Quarterly report, period 2025-03-31 | 0001628280-25-020341 |
| 2025-04-28 | 16:45 ET | [8-K](/filings/0001628280-25-020336.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-020336 |
| 2025-02-18 | 16:50 ET | [10-K](/filings/0001628280-25-006094.md) | Annual report, period 2024-12-31 | 0001628280-25-006094 |
| 2025-02-18 | 16:10 ET | [8-K](/filings/0001628280-25-006036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-006036 |
| 2024-11-04 | 16:50 ET | [10-Q](/filings/0001628280-24-045040.md) | Quarterly report, period 2024-09-30 | 0001628280-24-045040 |
| 2024-11-04 | 16:20 ET | [8-K](/filings/0001628280-24-045012.md) | 1.02 Termination of a material agreement; 2.02 Results of operations | 0001628280-24-045012 |
| 2024-08-05 | 16:50 ET | [10-Q](/filings/0001628280-24-034791.md) | Quarterly report, period 2024-06-30 | 0001628280-24-034791 |
| 2024-08-05 | 16:16 ET | [8-K](/filings/0001628280-24-034743.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-034743 |
| 2024-06-21 | 17:13 ET | [8-K](/filings/0001628280-24-029369.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-029369 |
| 2024-04-29 | 16:51 ET | [10-Q](/filings/0001628280-24-019046.md) | Quarterly report, period 2024-03-31 | 0001628280-24-019046 |
| 2024-04-29 | 16:36 ET | [8-K](/filings/0001628280-24-019030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-019030 |
| 2024-04-26 | 17:17 ET | [DEF 14A](/filings/0001628280-24-018731.md) | Proxy statement, period 2024-06-19 | 0001628280-24-018731 |
| 2024-02-20 | 17:23 ET | [8-K](/filings/0001628280-24-005673.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-005673 |
| 2024-02-20 | 16:50 ET | [10-K](/filings/0001628280-24-005620.md) | Annual report, period 2023-12-31 | 0001628280-24-005620 |
| 2023-12-13 | 07:42 ET | [8-K](/filings/0001628280-23-041392.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-041392 |
| 2023-11-06 | 16:50 ET | [10-Q](/filings/0001628280-23-037080.md) | Quarterly report, period 2023-09-30 | 0001628280-23-037080 |
| 2023-11-06 | 16:16 ET | [8-K](/filings/0001628280-23-037043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-037043 |
| 2023-09-27 | 08:30 ET | [8-K](/filings/0001628280-23-033071.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-033071 |
| 2023-09-07 | 16:08 ET | [8-K](/filings/0001628280-23-031708.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-031708 |
| 2023-08-07 | 17:15 ET | [8-K](/filings/0001628280-23-027839.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-027839 |
| 2023-08-07 | 16:50 ET | [10-Q](/filings/0001628280-23-027815.md) | Quarterly report, period 2023-06-30 | 0001628280-23-027815 |
| 2023-06-15 | 16:17 ET | [8-K](/filings/0001628280-23-022233.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-022233 |
| 2023-06-01 | 17:16 ET | [8-K](/filings/0001628280-23-020530.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-020530 |
| 2023-05-01 | 16:47 ET | [10-Q](/filings/0001628280-23-014622.md) | Quarterly report, period 2023-03-31 | 0001628280-23-014622 |
| 2023-05-01 | 16:06 ET | [8-K](/filings/0001628280-23-014561.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-014561 |
| 2023-05-01 | 08:39 ET | [DEF 14A](/filings/0001628280-23-014346.md) | Proxy statement | 0001628280-23-014346 |
| 2023-04-20 | 17:28 ET | [8-K](/filings/0001628280-23-012300.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-23-012300 |
| 2023-03-16 | 16:20 ET | [8-K](/filings/0001628280-23-008303.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-008303 |

Page 1 of 7. [Older](/companies/med/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 31, 2026, 14:35 ET. No prices; not investment advice.